Welcome to our dedicated page for Ascend Wellness SEC filings (Ticker: AAWH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings and related disclosures for Ascend Wellness Holdings, Inc. (AWH), associated with the symbol AAWH. As a vertically integrated, multi-state cannabis operator with securities trading on the CSE and OTCQX, AWH furnishes certain information to the SEC, including current reports on Form 8-K that incorporate its earnings press releases and other material updates.
In its SEC filings, AWH reports details on quarterly and annual financial performance, capital structure, and significant corporate events. For example, a Form 8-K dated November 10, 2025, furnishes a press release announcing financial results for the quarter ended September 30, 2025. These filings describe revenue from retail and wholesale channels, gross profit and margin metrics, non-GAAP measures such as Adjusted EBITDA and Adjusted Gross Profit, and information on cash, debt, and Net Debt as defined by the company.
Filings and attached exhibits also outline financing transactions, such as private placements of 12.75% Senior Secured Notes due 2029 and secured mortgage loans backed by real estate in Ohio. Disclosures explain how proceeds are used, the interest rates and maturities of the notes, and how these instruments fit into AWH’s broader refinancing and capital structure plans.
Investors reviewing AWH’s filings can expect to find:
- Current reports on Form 8-K furnishing earnings press releases and other material events.
- Discussion of non-GAAP metrics, with definitions and reconciliations to GAAP measures in attached schedules.
- Information on debt facilities, note offerings, and mortgage financings, including key terms and security.
- Context on share repurchase activity under the company’s normal course issuer bid program.
On Stock Titan, SEC filings for AAWH are paired with AI-powered summaries that highlight key figures, capital structure changes, and operational themes, helping readers quickly interpret long documents. Real-time updates from EDGAR ensure that new 8-Ks and other relevant filings appear promptly, while AI-generated explanations clarify the significance of items such as financing transactions, non-GAAP definitions, and management’s commentary on performance.
Ascend Wellness Holdings, Inc. disclosed an adverse arbitration outcome related to a 2018 side letter with Green Thumb Industries. The arbitrator found that both parties breached the agreement’s purchase obligations and awarded Green Thumb about $22 million in damages and Ascend about $2.3 million, resulting in a net award to Green Thumb of roughly $19.7 million. Ascend disagrees with the decision and is evaluating its options but does not currently expect the award to cause any material disruption to its ongoing operations.
Ascend Wellness Holdings, Inc. has filed a shelf registration covering up to $100,000,000 of securities it may offer and sell from time to time. The company can issue Class A common stock, preferred stock, warrants, debt securities, subscription rights, or units in one or more future offerings, with final terms for each sale to be detailed in a separate prospectus supplement.
Ascend is a vertically integrated multi-state cannabis operator focused on limited-license adult-use markets. As of December 18, 2025, it operates 46 dispensaries, including 8 partner locations, across Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania, and runs cultivation facilities in six states with about 258,000 square feet of canopy. Its Class A common stock trades on the CSE under “AAWH.U” and on the OTCQX under “AAWH.”
Ascend Wellness Holdings (AAWH) reported softer results for the quarter ended September 30, 2025. Revenue was $124.7 million, down from $141.6 million a year ago, as both retail and third‑party wholesale sales declined. Gross profit held roughly steady, but operating expenses kept the business near break‑even at the operating line, and interest expense weighed on results. The company posted a net loss of $25.8 million, versus a $28.3 million loss last year.
For the first nine months of 2025, revenue totaled $380.0 million with a net loss of $69.5 million. AAWH ended the quarter with cash of $87.3 million, long‑term debt of $343.7 million, and stockholders’ equity of $2.6 million. Management disclosed indicators raising substantial doubt about going concern, but said this was alleviated by cash on hand and $21.7 million of net cash provided by operating activities year‑to‑date. The company completed several tuck‑in transactions for dispensaries and licenses during 2025. As of November 6, 2025, Class A shares outstanding were 202,269,004, with 65,000 Class B shares.
Ascend Wellness Holdings (AAWH) furnished quarterly results. The company reported that it issued a press release announcing financial results for the quarter ended September 30, 2025, and furnished it as Exhibit 99.1 to an 8-K.
The information was provided under Item 2.02 and is designated as “furnished,” not “filed,” which limits its use under the Exchange Act. The press release is dated November 10, 2025, and the 8-K was signed by Chief Financial Officer Roman Nemchenko.
FAQ
What is the current stock price of Ascend Wellness (AAWH)?
What is the market cap of Ascend Wellness (AAWH)?
